In patients undergoing percutaneous coronary intervention (PCI), intensifying antiplatelet therapy based on platelet reactivity testing reduces cardiovascular mortality and stent thrombosis, according ...

Researchers have identified serine threonine kinase 10 as a key regulator of platelet function, haemostasis and ...

Haemonetics Corporation HAE recently initiated commercial roll out of its four-channel TEG 6s PlateletMapping ADP & AA assay cartridge globally. Designed to be used with the TEG 6s Hemostasis Analyzer ...

Ado-trastuzumab emtansine (T-DM1) treatment results in grade 3-4 thrombocytopenia in 8%-13% of patients. Prior in vitro studies reported T-DM1 inhibition of megakaryocyte maturation as the cause of ...

Patients on prasugrel therapy have greater platelet inhibition than those taking maintenance doses of clopidogrel and thus require a longer time to return to baseline reactivity after stopping the ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

Barcelona, Spain, 31 August: Studies from a growing body of convincing data show that responsiveness to antiplatelet therapy is real. This is a clinically important issue and there is a need to ...

Platelets are small types of blood cells that prevent excessive bleeding. It’s possible to develop low or high platelet counts related to a number of health conditions. Platelets are one of the main ...

February 2, 2007 (Jacksonville, FL) - A 150-mg maintenance dose of clopidogrel may be more appropriate than the standard 75-mg dose for patients with type 2 diabetes who are at higher risk of ...